Advertisement: Kao Data Centre mid banner
Advertisement: Simpsons Creative
CBM light up lives mid banner advert
Advertisement – Charles Stanley mid banner
Advertisement: Wild Knight Vodka
Advertisement: EY Mid banner
Advertisement: CJBS mid banner
Mid banner advertisement: BDO
Advertisement: S-Tech mid banner 3
Advertisement: RSM
Advertisement: Hewitsons mid banner
Advertisement: Cambridge Network mid banner
Advertisement: TTP
Advertisement: Howard Group mid banner
Advertisement: Mogrify mid banner
Advertisement: EBCam mid banner
ARM Innovation Hub
Barr Ellison Solicitors – commercial property
21 April, 2021 - 21:43 By Tony Quested

IQ Capital founder takes chair role at BVCA

IQ capital managing partner Kerry Baldwin has been appointed chair of The British Private Equity and Venture Capital Association (BVCA).

Founder and Managing Partner of IQ Capital, Kerry Baldwin is one of the UK’s most experienced venture capital investors and brings to the role more than 20 years’ experience in deep tech venture capital. She will be chair of the BVCA Council until March 31, 2022.

She was BVCA Vice Chair of Council for the past year and closely involved in the Association’s work on behalf of the private equity and venture capital industry. In an intense period focused on COVID-19, the final stages of Brexit and the review of capital gains tax, she has already been heavily engaged in the BVCA’s work with the industry and government.

In addition, she supported a number of Government policy priorities, working on many measures for the private equity and venture capital ecosystem to aid the UK’s ‘Science Superpower’ agenda. This includes highlighting the fundraising challenges life science, biotech and deep tech founders and venture capital funds encountered at the start of lockdown, the creation of the Future Fund and close collaboration with industry stakeholders on science and technology industry cohesion.

Originally with BDO Stoy Hayward, she joined Venture Technologies in 1998, investing in the first wave of UK deep tech companies and has focussed on deep tech early stage investing ever since.

Kerry heads up IQ’s Cybersecurity, Supervisory tech, big data and neurotech portfolio, specialising in Go-To-Market, Strategic Marketing, Competitive Intelligence, sits on several boards including FNA, CyberSmart, BMLL Technologies, Cybsafe, Divido and Neurovalens, and has conducted many exits and IPOs. She is a Fellow in Entrepreneurship at the University of Cambridge’s Judge Business School.

She said: “I’m delighted to be representing the entire private equity and venture capital ecosystem as Chair of the BVCA, taking over from Neil MacDougall who has done a tremendous job. The industry is primed to support stakeholders on a number of pressing public policy priorities and I am excited to be in the position to champion the value created, both economically and socially, by the BVCA’s members across the next 12 months.

“It is these members who will unleash the true potential of businesses across the country, ensuring that the UK remains the best place for innovation to thrive and the destination for both founders and asset managers to deliver the economic recovery.”

Michael Moore, Director General of the BVCA, said: “Everyone at the BVCA is thrilled to welcome Kerry as Chair at what is a key moment for our industry as we look to support a growth-led economic recovery for the UK. I am certain that the wealth of experience and energy she brings with her will prove to be invaluable in taking us forward over the next year, as will her unwavering support for the public value that our members create for the country as a whole.”

Earlier this month IQ Capital promoted Jo Slota-Newson to Principal. She has worked with a number of companies in IQ Capital’s deeptech portfolio including Porotech, Cambridge GaN Devices, Closed Loop Medicine and Nyobolt. Prior to joining IQ Capital, she was Investment Manager at Mercia Asset Management. 

She was also CTO and Operations Lead for an early-stage photovoltaics company, where she managed industrial collaborations, launched new products, and oversaw sales to major UK corporates. Jo also co-founded an online equity investment platform to syndicate deals in the Life Sciences and Biotech sectors, supporting early-stage ventures with promising technical solutions in identified target markets.

Kerry Baldwin said: “Jo has proven to be an invaluable member of the team since she joined IQ Capital, and her promotion reflects the great contribution she’s made to the portfolio. Jo has already led great investments, such as Cambridge GaN Devices, and we are all very excited that she’s taking up this leading role as Principal.”

Newsletter Subscription

Stay informed of the latest news and features